Ізраїль - іврит - Ministry of Health

lapidot medical import and marketing ltd - calcium chloride dihydrate; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate; sodium chloride; succinylated gelatin - תמיסה לאינפוזיה - succinylated gelatin 40 mg/ml l; magnesium chloride hexahydrate 0.20 mg/ml l; calcium chloride dihydrate 0.15 mg/ml l; potassium chloride 0.30 mg/ml l; sodium acetate trihydrate 3.27 mg/ml l; sodium chloride 5.55 mg/ml l - gelatin agents

Ізраїль - іврит - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - תמיסה לאינפוזיה - amikacin as sulfate 10 mg / 1 ml - amikacin

Ізраїль - іврит - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - תמיסה לאינפוזיה - amikacin as sulfate 5 mg / 1 ml - amikacin

Ізраїль - іврит - Ministry of Health

lapidot medical import and marketing ltd - omega-3; soya bean oil, refined; triglycerides, medium-chain - תחליב לאינפוזיה - omega-3 20 mg / 1 ml; soya bean oil, refined 80 mg / 1 ml; triglycerides, medium-chain 100 mg / 1 ml - fat emulsions

Ізраїль - іврит - Ministry of Health

lapidot medical import and marketing ltd - heparin sodium - תמיסה להזרקה\אינפוזיה - heparin sodium 5000 iu - heparin

Ізраїль - іврит - Ministry of Health

a.lapidot pharmaceuticals ltd, israel - chlorhexidine dihydrochloride; lidocaine hydrochloride - ג'ל - lidocaine hydrochloride 2 %w/w; chlorhexidine dihydrochloride 0.05 %w/w - lidocaine - lidocaine - instillation into the urethra prior to the instillation of catheters or other instruments and manipulations which require the use of a local anesthetic.

Ізраїль - іврит - Ministry of Health

a. lapidot pharmaceuticals, ltd - mifepristone - טבליה - mifepristone 200 mg - mifepristone - mifepristone - medical alternative to uterine suction for termination of intra-utrerine pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after mifegyne intake. under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Ізраїль - іврит - Ministry of Health

או.אס.איי. קוסמטיקס - לחות לכפות הרגליים

Ізраїль - іврит - Ministry of Health

או.אס.איי. קוסמטיקס - שיפור מראה העור

Ізраїль - іврит - Ministry of Health

מיסנס קוסמטיקס בעמ - טיפוח הגוף